• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Diagonal Bio

Less than 1K followers
Overview
Investor consensus
All
Press releases
ShowingAll content types

Regulatory press release11.12.2025, 13.50

Diagonal Bio has been declared in bankruptcy

Diagonal Bio
Regulatory press release11.12.2025, 10.45

Diagonal Bio intends to submit a formal application for bankruptcy

Diagonal Bio
Regulatory press release01.12.2025, 08.30

Nomination Committee appointed for Diagonal Bio

Diagonal Bio

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release04.11.2025, 09.30

Untersteiner Racing signs agreement for a pilot test

Diagonal Bio
Regulatory press release31.10.2025, 08.00

Diagonal Bio publishes interim report for the third quarter of 2025

Diagonal Bio
Press release13.10.2025, 09.00

Diagonal Bio launches new website to reflect commercial focus on the Animal Health segment

Diagonal Bio
Press release03.10.2025, 11.30

Diagonal Bio initiates collaboration with SVA on evaluation of coronavirus in horses

Diagonal Bio
Regulatory press release23.09.2025, 11.15

Diagonal Bio expands horse testing panel to detect Equine Herpesvirus type 2

Diagonal Bio
Regulatory press release18.09.2025, 13.00

Diagonal Bio receives order from Stall Courant

Diagonal Bio
Regulatory press release22.08.2025, 08.00

Diagonal Bio publishes interim report for the second quarter of 2025

Diagonal Bio
Press release20.08.2025, 08.00

Diagonal Bio AB receives patent approval in Japan

Diagonal Bio
Press release07.07.2025, 13.00

Diagonal Bio AB files patent application for Novel Computational Method that significantly improves LAMP primer design

Diagonal Bio
Regulatory press release25.06.2025, 13.00

The Board of Directors of Diagonal Bio carries out a directed issue to underwriters in connection with exercise of warrants of series TO 2

Diagonal Bio
Regulatory press release19.06.2025, 13.40

Diagonal Bio receives SEK 3.6 million through exercise of warrants of series TO 2

Diagonal Bio
Regulatory press release17.06.2025, 18.47

Update regarding large shareholder’s exercise of warrants of series TO 2

Diagonal Bio
Regulatory press release17.06.2025, 08.30

Diagonal Bio expands equine panel with addition of strangles

Diagonal Bio
Regulatory press release16.06.2025, 08.30

Large shareholder exercises warrants of series TO 2

Diagonal Bio
Regulatory press release13.06.2025, 08.00

Last day of trading in Diagonal Bio’s warrants of series TO 2 is 16 June 2025

Diagonal Bio
Press release11.06.2025, 11.30

Diagonal Bio shares progress update on LAMPlify® commercial pilots

Diagonal Bio
Regulatory press release09.06.2025, 14.00

Svea Bank AB invests SEK 0.5 million in Diagonal Bio AB through the exercise of warrants of series TO 2

Diagonal Bio